MINOLI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.945
EU - Europa 1.339
AS - Asia 1.006
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.296
Nazione #
US - Stati Uniti d'America 1.936
CN - Cina 905
IE - Irlanda 375
UA - Ucraina 298
FI - Finlandia 178
DE - Germania 176
IT - Italia 96
SG - Singapore 89
GB - Regno Unito 78
SE - Svezia 76
FR - Francia 37
BE - Belgio 10
IN - India 8
RU - Federazione Russa 8
CA - Canada 7
CZ - Repubblica Ceca 3
ES - Italia 2
GT - Guatemala 2
JP - Giappone 2
MU - Mauritius 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
EC - Ecuador 1
EU - Europa 1
IR - Iran 1
NL - Olanda 1
PT - Portogallo 1
Totale 4.296
Città #
Chandler 464
Dublin 375
Jacksonville 370
Nanjing 257
Boardman 144
Nanchang 120
Ashburn 106
Princeton 84
Hebei 82
Wilmington 82
Lawrence 81
Shenyang 81
Changsha 76
Beijing 75
Ann Arbor 67
Singapore 63
Jiaxing 59
Tianjin 55
Medford 54
Hangzhou 41
Helsinki 28
Milan 28
Verona 25
Shanghai 23
Woodbridge 21
Des Moines 11
Brussels 10
New York 10
Pavia 10
Kunming 9
Auburn Hills 8
Norwalk 8
Fairfield 7
Los Angeles 7
Munich 7
Seattle 7
Toronto 7
Pune 6
Houston 5
Jinan 5
Guangzhou 4
Berlin 3
Besana in Brianza 3
Brno 3
Ningbo 3
Norwich 3
Taizhou 3
El Salvador 2
Falkenstein 2
Monmouth Junction 2
Montepaone Lido 2
Moscow 2
Mountain View 2
Orange 2
Pittsburgh 2
Rockville 2
Romainville 2
Rome 2
San Francisco 2
Scuola 2
St Petersburg 2
Tappahannock 2
Tokyo 2
Tradate 2
Washington 2
Zhengzhou 2
Andover 1
Brescia 1
Dallas 1
Dearborn 1
Dubai 1
Eindhoven 1
Florence 1
Gussago 1
Las Vegas 1
Lisbon 1
London 1
Mcallen 1
Nizhniy Novgorod 1
Nürnberg 1
Phoenix 1
Pompei 1
Pontevedra 1
Quito 1
Reading 1
Rozzano 1
Sacramento 1
San Giuliano Milanese 1
Santa Clara 1
Serra 1
Shaoxing 1
Southend 1
Trento 1
Triuggio 1
Vigevano 1
Totale 3.067
Nome #
A new chromosome instability disorder 90
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 89
Postinfectious neurologic syndromes: A prospective cohort study 86
Listeriosi 78
Candida infective endocarditis: report of 15 cases from a prospective multicenter study 77
Acute disseminated encephalomyelitis 76
Sepsi e shock settico 73
Carbonchio 73
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 73
Severe recurrent myelitis in patients with hepatitis C virus infection 72
A 10-years survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian report 70
Long-term CD4+ T- cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 67
Acute transient inflammatory leukoencephalopathy in HIV. 65
Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients 64
Severe steroid-resistant post-infectious encephalomyelitis: general features and effects ofIVIg. 63
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1 positive patients after commencement of a new highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER COHORT 63
Prevalence and outcome of hepatitis B virus (HBV) infection following thoracic organ transplantation 63
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 63
Infezioni da Brucella 62
Osteomieliti e artriti infettive 62
Severe recurrent myelitis in patients with hepatitis C virus infection patients 61
Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus 61
Xenotropic and polytropic murine leukemia virus-related sequences are not detected in the majority of patients with chronic fatigue syndrome. 61
Headache attributed to infection: observations on the IHS classification (ICHD-II) 60
Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3 60
Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicenter study. 60
Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients. 60
Malatttie da Rickettsie 59
Predictors of AIDS-defining events among advanced naive patients after HAART 59
Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors 59
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection 59
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 59
Morphological, cytochemical and ultrastructural studies of a case of systemic mastocytosis. 58
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 58
HIV-RELATED ACUTE INFLAMMATORY LEUKOENCEPHALOPATHY OF UNDETERMINED ORIGIN: SYSTEMATIC REVIEW OF THE LITERATURE 58
Infezioni da Legionella 57
Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient 57
Febbri ricorrenti 56
First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection 56
Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linted immunospot assay. 55
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease 54
Comparison of four-drug regimens and pairs of sequential three drug regimens as initial therapy for HIV-1 infection 53
Exploratory analysis for the evaluation of lopinavir/ritonavir versus efavirenz- based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER COHORT 52
Visceral leishmaniasis, systemic lupus erythematosus and acute hepatitis 52
Replication capacity in relation to immunological and virological outcomes in HIV-1 infected treatment-naive subjects 52
Circadian secretory pattern of growth hormone, insulin-like growth type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection 52
Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study 51
Infectious complications in patients with the novacor left ventricular assist system 51
Immune reconstitution and control of HIV 51
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal 50
Staphylococcus aureus toxic shock syndrome toxin-1 endocarditis with muscular metastatic abscesses 50
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort 49
Post infectious inflammatory disorders: subgroup based on prospective follow-up 49
The effect of HIV-1 resistance mutatioins after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens 47
Post-exposure rate of tuberculosis infection among health care workers measured with tuberculin skin test convension after unprotected exposure to patients with pulmonary tuberculosis: 6 -years experience in an Italian teaching hospital 47
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study 46
Leptospirosi 45
Epidemiology of Mycobacterium tuberculosis infecion in Pavia province, Lombarady, Northern Italy, 1998-2013 45
Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus. 44
Performance of liver stiffness measurements by transient elastography in chronic hepatitis. 44
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 43
Aetiology and outcome of penumoniae in HIV-positive patients in the antiretroviral era 43
Evaluation of cytomegalovirus DNAemia versus pp65-antigenemia cut off for guiding preemptive therapy in transplant recipients: a randomized study 43
ItalianPostinfectious Demyelinating Diseases (IPoDD) Study Group; Italian Study Group ofNeuroinfectious Diseases. Recruitment criteria for acute disseminatedencephalomyelitis studies: the need for consensus 42
Riverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study 42
Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: Case report and review of the literature 42
In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis; high in vitro synergistic effect of the association ceftriaxone-fosfomycin. 41
Vademecum di Malattie Infettive 40
Predictors of clinical progression among HIV-1 positive patients starting HAART with CD4+ T-cell counts > or= 200 cells/mm3 39
The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens 39
Tuberculosis-induced haemophagocytic syndrome in a patient on haemodialysis treated with anti-thymocyte globulin. 37
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz 36
Surveillance of Toxoplasma gondii infection in recipients of thoracic solid organ transplants 35
Neuropsychological evaluation and follow up in jcv- and non-jcv-related leukoencephalopathies in HIVinfection 35
Profilassi e terapia delle infezioni micotiche nel trapianto d'organo solido. 30
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 30
Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients. 29
Performance of liver stiffness measurements by transient elastography in chronic hepatitis. 29
Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients. 22
Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized-double-blind SENSE trial 22
Infective endocarditis in patients with hepatic diseases 21
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 14
Totale 4.340
Categoria #
all - tutte 17.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020278 0 0 0 0 0 60 11 59 3 112 30 3
2020/2021509 61 50 13 60 3 68 1 83 12 76 70 12
2021/2022308 2 7 10 7 3 6 4 20 19 2 54 174
2022/20231.237 143 86 17 126 120 144 0 69 487 0 28 17
2023/2024322 39 62 9 24 19 87 1 29 6 4 15 27
2024/2025212 17 89 24 33 21 28 0 0 0 0 0 0
Totale 4.340